AZ HB2454

Requires department approval before prescribing antipsychotic or neuroleptic medications to children under five years old in state care, considering the child's diagnosis, FDA approval status, prior medication history, and other relevant factors.

Mandates a biennial report (every odd-numbered year) comparing psychotropic medication prescription rates between foster children and non-foster children enrolled in the Arizona health care cost containment system.

Report must include prescription data by age group and medication type, number of prescriptions per child, provider information, compliance with informed consent requirements, and annual medication costs.

Defines "psychotropic medication" to include psychomotor stimulants, antidepressants, antipsychotics, mood stabilizers, antianxiety agents, and sedative/hypnotic medications used to treat mental health and behavioral conditions.

Allows the department of child safety to delay implementation if federal waiver or authorization is required.